| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-08 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.27 | 8e-08 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.27 | 2e-07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.24 | 1e-05 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.21 | 0.0001 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |